PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-96.30%
Negative 10Y revenue/share CAGR while ANO.AX stands at 270.11%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-57.39%
Negative 5Y CAGR while ANO.AX stands at 56.98%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-55.96%
Negative 3Y CAGR while ANO.AX stands at 49.89%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-103.53%
Negative 10Y OCF/share CAGR while ANO.AX stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
83.39%
OCF/share CAGR of 83.39% while ANO.AX is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
-123.37%
Negative 3Y OCF/share CAGR while ANO.AX stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
No Data
No Data available this quarter, please select a different quarter.
103.52%
5Y net income/share CAGR above 1.5x ANO.AX's 45.24%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
126.47%
3Y net income/share CAGR above 1.5x ANO.AX's 59.08%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.